Benjamin G. Barwick

4.6k total citations · 1 hit paper
72 papers, 3.0k citations indexed

About

Benjamin G. Barwick is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Benjamin G. Barwick has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 27 papers in Hematology and 20 papers in Immunology. Recurrent topics in Benjamin G. Barwick's work include Multiple Myeloma Research and Treatments (27 papers), Immune Cell Function and Interaction (15 papers) and Epigenetics and DNA Methylation (14 papers). Benjamin G. Barwick is often cited by papers focused on Multiple Myeloma Research and Treatments (27 papers), Immune Cell Function and Interaction (15 papers) and Epigenetics and DNA Methylation (14 papers). Benjamin G. Barwick collaborates with scholars based in United States, Canada and China. Benjamin G. Barwick's co-authors include Jeremy M. Boss, Christopher D. Scharer, Lawrence Boise, Paula M. Vertino, Alexander P. R. Bally, Vikas A. Gupta, Karen N. Conneely, Sagar Lonial, Pankaj Chopra and Glen A. Satten and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Benjamin G. Barwick

70 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

2022 168 citations Nataliya Prokhnevska, Maria A. Cardenas et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin G. Barwick United States	29	1.8k	886	826	513	409	72	3.0k
Anna Kiialainen Switzerland	19	988 0.5×	1.2k 1.3×	1.0k 1.3×	534 1.0×	335 0.8×	35	2.9k
Patrick A. Zweidler‐McKay United States	35	1.8k 1.0×	632 0.7×	1.1k 1.3×	839 1.6×	690 1.7×	128	3.7k
Bin Pan China	25	1.7k 0.9×	631 0.7×	539 0.7×	352 0.7×	759 1.9×	106	2.9k
Claudia Lengerke Germany	33	2.6k 1.4×	743 0.8×	959 1.2×	771 1.5×	604 1.5×	131	4.6k
Stephen M. Sykes United States	27	2.4k 1.3×	382 0.4×	996 1.2×	765 1.5×	387 0.9×	80	3.6k
Sridhar Rao United States	27	2.5k 1.4×	606 0.7×	405 0.5×	291 0.6×	341 0.8×	89	3.5k
Antonio Giovanni Solimando Italy	38	1.3k 0.7×	500 0.6×	1.1k 1.3×	689 1.3×	675 1.7×	129	3.1k
Steven Goossens Belgium	26	1.9k 1.0×	409 0.5×	805 1.0×	202 0.4×	649 1.6×	71	3.0k
Mark Lupher United States	27	1.6k 0.9×	1.3k 1.5×	596 0.7×	226 0.4×	218 0.5×	38	3.4k
Lars H. Engelholm Denmark	31	1.3k 0.7×	571 0.6×	1.1k 1.3×	330 0.6×	1.2k 2.8×	79	3.4k

Countries citing papers authored by Benjamin G. Barwick

Since Specialization

Citations

This map shows the geographic impact of Benjamin G. Barwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin G. Barwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin G. Barwick more than expected).

Fields of papers citing papers by Benjamin G. Barwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin G. Barwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin G. Barwick. The network helps show where Benjamin G. Barwick may publish in the future.

Co-authorship network of co-authors of Benjamin G. Barwick

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin G. Barwick. A scholar is included among the top collaborators of Benjamin G. Barwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin G. Barwick. Benjamin G. Barwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riva, Alberto, Benjamin G. Barwick, Sayantan Maji, et al.. (2024). KDM6A regulates immune response genes in multiple myeloma. Blood. 144(14). 1508–1520. 5 indexed citations

Moreno, Carlos S., Mehrdad Alemozaffar, Ismaheel O. Lawal, et al.. (2023). Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. Cancers. 15(23). 5671–5671. 3 indexed citations

Leblay, Noémie, Sungwoo Ahn, Mansour Poorebrahim, et al.. (2023). Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency. Blood. 143(1). 42–56. 14 indexed citations

Barwick, Benjamin G., et al.. (2023). SDC2 Expression Is Increased in Myeloma Cells in Response to Loss of Pro-Survival Surface Proteins, CD28 and CD86. Blood. 142(Supplement 1). 3299–3299. 1 indexed citations

Barwick, Benjamin G., et al.. (2022). PDZ Proteins SCRIB and DLG1 Regulate Myeloma Cell Surface CD86 Expression, Growth, and Survival. Molecular Cancer Research. 20(7). 1122–1136. 5 indexed citations

Nair, Remya, Abhinav Achreja, Anjali Mittal, et al.. (2022). Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma. Science Advances. 8(39). eabq5575–eabq5575. 12 indexed citations

Dammer, Eric B., Fengxia Yan, Sanjay Jain, et al.. (2022). Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers. 14(9). 2228–2228. 3 indexed citations

Prokhnevska, Nataliya, Maria A. Cardenas, Rajesh M. Valanparambil, et al.. (2022). CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity. 56(1). 107–124.e5. 168 indexed citations breakdown →

Kaushal, Akhilesh, Ajay K. Nooka, Katherine E. Pendleton, et al.. (2021). Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia. Blood Cancer Discovery. 2(6). 600–615. 14 indexed citations

10.

Barwick, Benjamin G., Vikas A. Gupta, Shannon M. Matulis, et al.. (2021). Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma. Clinical Cancer Research. 27(11). 3178–3189. 10 indexed citations

11.

Bajpai, Richa, Aditi Sharma, Abhinav Achreja, et al.. (2020). Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nature Communications. 11(1). 1228–1228. 76 indexed citations

12.

Gu, Yanyan, Benjamin G. Barwick, Mala Shanmugam, et al.. (2020). Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma. Blood Cancer Journal. 10(12). 125–125. 9 indexed citations

13.

Konen, Jessica, Bhakti Dwivedi, Manali Rupji, et al.. (2019). Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes. Journal of Cell Science. 132(19). 27 indexed citations

14.

Lin, Yu-Hsiu T., Gregory P. Way, Benjamin G. Barwick, et al.. (2019). Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma. Blood Advances. 3(21). 3214–3227. 14 indexed citations

15.

Schmidt, Timothy M., Benjamin G. Barwick, Nisha S. Joseph, et al.. (2019). Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer Journal. 9(12). 94–94. 108 indexed citations

16.

Barwick, Benjamin G., Vikas A. Gupta, Paula M. Vertino, & Lawrence Boise. (2019). Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma. Frontiers in Immunology. 10. 1121–1121. 114 indexed citations

17.

Kennedy, Elizabeth M., David Powell, Joshua S. K. Bell, et al.. (2018). Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer. Scientific Reports. 8(1). 6709–6709. 25 indexed citations

18.

Barwick, Benjamin G., Vikas A. Gupta, Daniel Auclair, et al.. (2017). High-Risk Myeloma Is Demarcated By Immunoglobulin Lambda Light Chain Translocations. Blood. 130. 1780–1780. 1 indexed citations

19.

Wang, Dongxue, Hideharu Hashimoto, Xing Zhang, et al.. (2016). MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma. Nucleic Acids Research. 45(5). 2396–2407. 61 indexed citations

20.

Duncan, Christopher G., Benjamin G. Barwick, Genglin Jin, et al.. (2012). A heterozygous IDH1^R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Research. 22(12). 2339–2355. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact